Delogu, G.L.; Begala, M.; Novás, M.; Matos, M.J.; Piras, F.; Floris, S.; Pintus, F.; Mancinelli, M.; Era, B.; Fais, A.
2-Arylbenzofurans as Selective Cholinesterase Inhibitors: Design, Synthesis, and Evaluation as Alzheimer’s Disease Agents. Biomolecules 2026, 16, 178.
https://doi.org/10.3390/biom16010178
AMA Style
Delogu GL, Begala M, Novás M, Matos MJ, Piras F, Floris S, Pintus F, Mancinelli M, Era B, Fais A.
2-Arylbenzofurans as Selective Cholinesterase Inhibitors: Design, Synthesis, and Evaluation as Alzheimer’s Disease Agents. Biomolecules. 2026; 16(1):178.
https://doi.org/10.3390/biom16010178
Chicago/Turabian Style
Delogu, Giovanna Lucia, Michela Begala, Manuel Novás, Maria João Matos, Franca Piras, Sonia Floris, Francesca Pintus, Michele Mancinelli, Benedetta Era, and Antonella Fais.
2026. "2-Arylbenzofurans as Selective Cholinesterase Inhibitors: Design, Synthesis, and Evaluation as Alzheimer’s Disease Agents" Biomolecules 16, no. 1: 178.
https://doi.org/10.3390/biom16010178
APA Style
Delogu, G. L., Begala, M., Novás, M., Matos, M. J., Piras, F., Floris, S., Pintus, F., Mancinelli, M., Era, B., & Fais, A.
(2026). 2-Arylbenzofurans as Selective Cholinesterase Inhibitors: Design, Synthesis, and Evaluation as Alzheimer’s Disease Agents. Biomolecules, 16(1), 178.
https://doi.org/10.3390/biom16010178
